ALINT — IntegraGen SA Share News
0.000.00%
Last trade - 00:00- €0.46m
- -€0.35m
- €5.02m
Brief: Integragen FY Revenue Up At 6.9 Million Euros
Brief: Integragen Announces Collaboration With Google Cloud
Brief: Integragen H1 Operating Loss Narrows To 0.5 Million Euros
Brief: Integragen Announces Publication Of Data For MiR-31-3P
Brief: Integragen Selected By SeqOIA GCS As Operator Of Its Sequencing Platform
Brief: Integragen SA H1 Sales EUR 3.6 Million Up 17 Percent YoY
Brief: Integragen FY Net Loss Narrows To Eur 0.9 Million
Brief: Integragen Presents Positive Data From Liquid Biopsy Studies Of miRNAs
Brief: Integragen Announces Global Distribution Agreement With Twist Bioscience For Sirius And Mercury
Brief: IntegraGen Sa FY Revenue Up At Eur 6.2 Million
Brief: IntegraGen: Licensing Agreement with GoPath Laboratories For Commercialization Of miR-31-3p Test In North America
Brief: IntegraGen announces miR-31-3p publication in Oncotarget
Brief: Integragen H1 operating loss stable at 1.2 million euros
Brief: IntegraGen announces CE-IVD marking of miRpredX 31-3p kit
Brief: Integragen FY net loss widens to 1.7 million euros
Brief: Integragen and Laboratoire Cerba agree to commercialize tumor expression test
Brief: Integragen successfully completes 3.7 mln euro capital increase
Brief: Integragen reports sharp increase in sales during 2016
Brief: Integragen H1 net loss widens to 1.0 million euros